David A. Hormuth, MD
Professor of Surgery
Chair of Clerkship Education

dhormuth@marian.edu

Biography

David Hormuth MD, MBA is cardiothoracic surgeon with greater than 25 years of experience in private and academic practice.  His primary focus of cardiothoracic surgery, heart transplant, lung transplant and mechanical circulatory support began in medical school and continues today.  Dr. Hormuth has participated in more than 400 individual heart and lung transplants, implantation of the first total artificial heart in Indiana, and implantation of the first wearable ventricular assist device in Indiana while maintaining a thriving cardiothoracic surgery practice.  Dr. Hormuth has been nominated to America's Top Surgeons consecutively from 2007 through 2014 and is active in multiple professional societies, both locally and internationally.  Dr. Hormuth completed his MBA in the Business of Medicine at the Kelley School of Business/Indiana University.

Dr. Hormuth graduated from the Indiana University School of Medicine and completed a general surgery residency at Methodist Hospital in Indianapolis, serving as the program’s chief resident. He later completed a residency in cardiothoracic surgery at the Medical College of Wisconsin in Milwaukee. He is ABMS board certified in both General Surgery and Thoracic Surgery. Dr. Hormuth’s professional activities include more than 140 medical education presentations, articles in professional medical journals, and chapters in medical textbooks in his discipline.

Clinical/Research Interests

Dr. Hormuth’s current research includes the following:

  • Protocol 08-075 entitled "Role of inflammation, Thrombosis and Endothelial Activation as Risk Factors for the Prediction of Cardiac Allograft Vasculopathy (CAV) in Heart
  • Protocol 08-074 entitled "Role of inflammation, thrombosis and activation as risk factors for the prediction of Obliterative Bronchiolitis Syndrome (BOS) in Lung Transplant Patients".
  • Exclusion of the Left Atrial Appendage with the LAAx, Inc., TigerPaw™ System during Elective,
  • Non-Endoscopic Cardiac Surgery Procedures
  • Protocol 09 – 053 Evaluation of the HeartWare Left Ventricular Assist System for the Treatment of Advanced Heart Failure – Continued Access Protocol
  • A prospective, Randomized, Controlled, Un-blinded, Multi-center Clinical Trial to Evaluate the HeartWare® Left Ventricular Assist System for Destination Therapy of Advanced Heart Failure
  • Prospective, International, Multi-Center, Randomized Clinical Investigation of TransMedics® Organ Care System (OCSTM LUNG) for Lung Preservation and Transplantation
  • NORMOTHERMIC EX VIVO LUNG PERFUSION (EVLP) AS AN ASSESSMENT OF EXTENDED/MARGINAL DONOR LUNGS (NOVEL LUNG TRIAL)
  • Prosepctive, Multi-Center, Randomized Clinical Investigation of Transmedics® Organ Care SystemTM (OCS) For Cardiac Use

Can't Find What You're Looking For?

Search for it.